Molecular Therapy Oncology: review time and acceptance speed
ISSN 2950-3299 · Elsevier BV · Multidisciplinary
Half of the articles Molecular Therapy Oncology accepted in 2025 were accepted within 165 days of submission (n = 116); the middle half took 117–193 days.
Accepted articles only · dates deposited by the publisher in PubMed · data as of Sep 15, 2026
How long does Molecular Therapy Oncology take to accept a paper?
| Year | Articles (n) | 25th pct | Median | 75th pct | 90th pct | Accepted <14 days | Have a revised date |
|---|---|---|---|---|---|---|---|
| 2025 | 116 | 117 | 165 | 193 | — | 0.0% | 99% |
| 2024 | 110 | 108 | 154 | 210 | — | 0.0% | 93% |
- 2026: not shown yet — a year is reported once late-indexed articles have arrived (at least 180 days after it ends).
Distribution in 2025
Show as a table
| Days | Articles | Share |
|---|---|---|
| 0–29 | 0 | 0.0% |
| 30–59 | 3 | 2.6% |
| 60–89 | 11 | 9.5% |
| 90–119 | 19 | 16.4% |
| 120–149 | 17 | 14.7% |
| 150–179 | 24 | 20.7% |
| 180–209 | 16 | 13.8% |
| 210–239 | 9 | 7.8% |
| 240–269 | 3 | 2.6% |
| 270–299 | 5 | 4.3% |
| 300–329 | 5 | 4.3% |
| 330–359 | 3 | 2.6% |
| 360+ | 1 | 0.9% |
From acceptance to online publication
After acceptance, half of the 2025 articles appeared online within 3 days (middle half 3–5 days, n = 116).
From submission to online publication, the median was 168 days (middle half 121–197 days, n = 116).
Read these numbers carefully
- These times describe articles the journal accepted. Rejected manuscripts never appear in public data, so they cannot tell you how long a rejection takes.
- Dates are the ones the publisher deposited with PubMed. Some publishers record the date a revised manuscript arrived as the submission date, which makes review look faster.
- Invited articles and special issues can move faster than regular submissions.
Open access status and publishing fees
Open access (listed in DOAJ). Listed APC: $3,900 (DOAJ).
OpenAPC has fewer than 5 reported payments for this journal in 2023–2025, so no typical amount is shown.
Many journals waive or reduce fees for authors from eligible countries or institutions with publishing agreements — check with the journal and your library.
Integrity and indexing signals
Facts from public records, shown without judgement. See the methodology for why each can be worth a closer look.
| Listed in DOAJ | Yes (DOAJ record) |
|---|---|
| Articles indexed for MEDLINE in 2025 | None found (the journal may be in PubMed through PubMed Central instead) |
| Retractions | 0 retracted articles among 243 added to PubMed in 2021–2025 (0.00 per 1,000), per the Retraction Watch Database. |
| Accepted within 14 days of submission | 0.0% of 2025 articles |
| Publication volume | 133 articles added to PubMed in 2025 (+21% vs 2024). |
Topics and scope
- CAR-T cell therapy research (20% of indexed topics)
- Virus-based gene therapy research (17% of indexed topics)
- Immunotherapy and Immune Responses (8% of indexed topics)
- Immune Cell Function and Interaction (7% of indexed topics)
- Cancer Research and Treatments (7% of indexed topics)
- Cancer Immunotherapy and Biomarkers (4% of indexed topics)
Medicine journalsBiochemistry, Genetics and Molecular Biology journalsOncology journals
Similar journals — faster or cheaper, side by side
Journals publishing on the most similar topics (OpenAlex), ordered by similarity. Only 2025 figures are compared with the 2025 median of Molecular Therapy Oncology, 165 days.
| Paid APC median | DOAJ | MEDLINE | |||
|---|---|---|---|---|---|
| Cancer Gene Therapy | 146 (2025, n = 116) | ≈$4,990 | — | No | Yes |
| Molecular Therapy — Methods & Clinical Development | 159 (2025, n = 191) | $3,900 | $3,865 (8 payments) | Yes | No |
| Molecular Therapy | 146 (2025, n = 558) | ≈$4,500 | $4,012 (6 payments) | No | Yes |
| Gene Therapy | 169 (2025, n = 71) | ≈$3,790 | — | No | Yes |
| Cancer Immunology Research | 224 (2025, n = 136) | — | — | No | Yes |
| Current Gene Therapy | 98 (2025, n = 71) | — | — | No | Yes |
| Cell Reports Medicine | 232 (2025, n = 456) | $5,790 | $5,240 (23 payments) | Yes | Yes |
| Experimental Hematology and Oncology | 103 (2025, n = 90) | $3,390 | — | Yes | No |
No journals match these filters.
Frequently asked questions
How long does Molecular Therapy Oncology take to accept a paper?
Half of the articles Molecular Therapy Oncology accepted in 2025 were accepted within 165 days of submission (n = 116); the middle half took 117–193 days. Based on dates in PubMed for accepted articles only.
How long after acceptance are Molecular Therapy Oncology articles published online?
Half of the articles accepted in 2025 appeared online within 3 days of acceptance (n = 116).
Does Molecular Therapy Oncology charge an article processing charge (APC)?
Listed APC: $3,900 (DOAJ).
Sources and method
Journal identity: ISSN-L 2950-3299; NLM ID 9918752083706676; OpenAlex record. Speed figures use 116 articles accepted in 2025 with valid dates; excluded records for that year: none.
Spotted a problem with this journal's data, or are you the publisher? Report a correction or email rafiq@gradsummit.com. Verified errors are corrected within five business days.
Get the free Journal Submission Go/No-Go Checklist
The pre-submission checks from Write and Publish a Scientific Paper: journal fit, formatting, cover letter and reviewer suggestions. We’ll email you the download link.
Data sources. Submission, acceptance and publication dates: Courtesy of the U.S. National Library of Medicine (PubMed, entries through Sep 15, 2026). NLM does not endorse Journal Clock, and these figures may not reflect the most current PubMed data. Journal fees and open-access listing: DOAJ (CC0, retrieved Sep 16, 2026). Fees paid by institutions: OpenAPC (Open Database License, retrieved Sep 16, 2026). Retractions: Retraction Watch Database via Crossref (retrieved Sep 16, 2026). Journal identifiers and topics: OpenAlex (CC0). Currency conversion: ECB reference rates (Sep 15, 2026). How these numbers are calculated · For organisations.